Amcasertib
CAS No. 1129403-56-0
Amcasertib ( BBI-503 )
Catalog No. M10454 CAS No. 1129403-56-0
A small-molecule inhibitor that inhibits Nanog and other CSC (cancer stem cells) pathways by targeting kinases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 106 | In Stock |
|
10MG | 176 | In Stock |
|
25MG | 372 | In Stock |
|
50MG | 556 | In Stock |
|
100MG | 791 | In Stock |
|
500MG | 1611 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAmcasertib
-
NoteResearch use only, not for human use.
-
Brief DescriptionA small-molecule inhibitor that inhibits Nanog and other CSC (cancer stem cells) pathways by targeting kinases.
-
DescriptionA small-molecule inhibitor that inhibits Nanog and other CSC (cancer stem cells) pathways by targeting kinases; targets and inhibits one or more pathways involved in cancer stem cell survival, shows potential antineoplastic activity.Liver Cancer Phase 2 Clinical
-
SynonymsBBI-503
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaCancer
-
IndicationLiver Cancer
Chemical Information
-
CAS Number1129403-56-0
-
Formula Weight539.69
-
Molecular FormulaC31H33N5O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 30 mg/mL
-
SMILESO=C(C1=C(C)NC(/C=C2C(NC3=C/2C=C(C4=CSC(C5=CC=CC=C5)=N4)C=C3)=O)=C1C)NCCN(CC)CC
-
Chemical Name1H-Pyrrole-3-carboxamide, N-[2-(diethylamino)ethyl]-5-[[1,2-dihydro-2-oxo-5-(2-phenyl-4-thiazolyl)-3H-indol-3-ylidene]methyl]-2,4-dimethyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Marcucci F, et al. Front Oncol. 2016 May 10;6:115.
2. Iv Santaliz-Ruiz LE, et al. Int J Cancer. 2014 Dec 15;135(12):2741-8.
2. Iv Santaliz-Ruiz LE, et al. Int J Cancer. 2014 Dec 15;135(12):2741-8.
molnova catalog
related products
-
Sematilide HCl
Sematilide (CK-1752) is a class III antiarrhythmic. It is a selectively delayed rectifier K+ current (IKr) channel blocker.
-
Pterodonoic acid
Pterodonoic acid is a natural product for research related to life sciences.
-
CCF0058981
CCF0058981 is a SARS-CoV-2 inhibitor with low nanomolar biochemical inhibition and efficacy in cellular models comparable to that of Remdesivir.